MedPath

Viiv Healthcare UK Limited

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

140

Active:125
Completed:7

Trial Phases

3 Phases

Phase 1:96
Phase 3:9
Not Applicable:5

Drug Approvals

6

NMPA:6

Drug Approvals

Maraviroc Tablets

Product Name
马拉韦罗片
Approval Number
H20140204
Approval Date
Mar 21, 2014
NMPA

Maraviroc Tablets

Product Name
马拉韦罗片
Approval Number
H20140203
Approval Date
Mar 21, 2014
NMPA

Maraviroc Tablets

Product Name
马拉韦罗片
Approval Number
H20140199
Approval Date
Mar 21, 2014
NMPA

Maraviroc Tablets

Product Name
马拉韦罗片
Approval Number
H20140201
Approval Date
Mar 21, 2014
NMPA

Maraviroc Tablets

Product Name
马拉韦罗片
Approval Number
H20140200
Approval Date
Mar 21, 2014
NMPA

Maraviroc Tablets

Product Name
马拉韦罗片
Approval Number
H20140202
Approval Date
Mar 21, 2014
NMPA

Clinical Trials

Distribution across different clinical trial phases (110 trials with phase data)• Click on a phase to view related trials

Phase 1
96 (87.3%)
Phase 3
9 (8.2%)
Not Applicable
5 (4.5%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.